Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake

Affiliations

¹ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Kurani.Shaheen@mayo.edu.
² Department of Family Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: MacLaughlin.Kathy@mayo.edu.
³ Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA; Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: jacobson.robert@mayo.edu.
⁴ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: StSauver.Jennifer@mayo.edu.
⁵ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Jenkins.Gregory@mayo.edu.
⁶ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Fan.Chun@mayo.edu.
⁷ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: djacobsn@mayo.edu.
⁸ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: aInselman.Jonathan@mayo.edu.
⁹ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Zhu.Xuan@mayo.edu.
¹⁰ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Griffin.Joan@mayo.edu.
¹¹ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Rutten.Lila@mayo.edu.

PMID: 34916103
PMCID: PMC8778948
DOI: 10.1016/j.vaccine.2021.12.003

Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake

Shaheen Kurani et al. Vaccine. 2022.

. 2022 Jan 24;40(3):471-476.

doi: 10.1016/j.vaccine.2021.12.003. Epub 2021 Dec 13.

Authors

Affiliations

¹ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Kurani.Shaheen@mayo.edu.
² Department of Family Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: MacLaughlin.Kathy@mayo.edu.
³ Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA; Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: jacobson.robert@mayo.edu.
⁴ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: StSauver.Jennifer@mayo.edu.
⁵ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Jenkins.Gregory@mayo.edu.
⁶ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Fan.Chun@mayo.edu.
⁷ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: djacobsn@mayo.edu.
⁸ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: aInselman.Jonathan@mayo.edu.
⁹ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Zhu.Xuan@mayo.edu.
¹⁰ Division of Health Care Delivery Research, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Griffin.Joan@mayo.edu.
¹¹ Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA. Electronic address: Rutten.Lila@mayo.edu.

PMID: 34916103
PMCID: PMC8778948
DOI: 10.1016/j.vaccine.2021.12.003

Abstract

Importance: Despite availability of safe and effective human papillomavirus (HPV) vaccines, vaccination uptake remains low in the U.S. Research examining the impact of neighborhood socioeconomic status on HPV vaccination may help target interventions.

Objective: To examine the association between area deprivation and HPV vaccine initiation and completion.

Design, setting, participants: Retrospective cohort study of individuals aged 11-18 years residing in the upper Midwest region. Receipt of HPV vaccination was examined over a three-year follow-up period (01/01/2016-12/31/2018).

Main outcomes and measures: Outcomes of interest were initiation and completion of HPV vaccination. Demographic data were collected from the Rochester Epidemiology Project (REP). Area-level socioeconomic disadvantage was measured by calculating an Area Deprivation Index (ADI) score for each person, a measure of socioeconomic disadvantage derived from American Community Survey data. Multivariable mixed effect Cox proportional hazards models were used to examine the association of ADI quartiles (Q1-Q4) with HPV vaccine series initiation and completion, given initiation.

Results: Individuals residing in census block groups with higher deprivation had significantly lower likelihood of HPV vaccine initiation (Q2: HR = 0.91, 0.84-0.99 Q3: HR = 0.83, 0.76-0.90; Q4: HR = 0.84, 0.74-0.96) relative to those in the least-deprived block groups (Q1). Similarly, those living in block groups with higher deprivation had significantly lower likelihood of completion (Q2: HR = 0.91, 0.86-0.97; Q3: HR = 0.87, 0.81-0.94; Q4: HR = 0.82, 0.74-0.92) compared to individuals in the least-deprived block groups (Q1).

Conclusions and relevance: Lower probability of both HPV vaccine-series initiation and completion were observed in areas with greater deprivation. Our results can inform allocation of resources to increase HPV vaccination rates in our primary care practice and provide an example of leveraging public data to inform similar efforts across diverse health systems.

Keywords: Papillomavirus Infections; Papillomavirus vaccines; Social class; Socioeconomic factors; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

1. Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086. - PMC - PubMed
1. Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human Papillomavirus-Attributable Cancers - United States, 2012–2016. MMWR Morbidity and mortality weekly report. 2019;68(33):724–728. - PMC - PubMed
1. Centers for Disease Control and Prevention. Cancers Associated with Human Papillomavirus, United States—2013–2017. USCS Data Brief Web site. https://www.cdc.gov/cancer/uscs/about/data-briefs/no18-hpv-assoc-cancers.... Published 2020. Accessed April 2021.
1. Hirth J Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019;15(1):146–155. - PMC - PubMed
1. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247–1255. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake

Affiliations

Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical